Kerlone and Overdose - a phase IV clinical study of FDA data

Summary:

Overdose is reported as a side effect among people who take Kerlone (betaxolol hydrochloride), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Celexa, and have Convulsion.

The phase IV clinical study analyzes which people have Overdose when taking Kerlone. It is created by eHealthMe based on reports of 937 people who have side effects when taking Kerlone from the FDA, and is updated regularly.

What is Kerlone?

Kerlone has active ingredients of betaxolol hydrochloride. eHealthMe is studying from 941 Kerlone users. Check the latest studies of Kerlone.

What is Overdose?

Overdose is found to be associated with 2,217 drugs and 2,472 conditions by eHealthMe. Check the latest studies of Overdose.

On Jul, 15, 2026

937 people reported to have side effects when taking Kerlone.
Among them, 13 people (1.39%) have Overdose.

Among these 13 people:

How long have people been on Kerlone when they have Overdose? *

What is the gender of people who have Overdose when taking Kerlone? *

female: 69.23 %
male: 30.77 %

What is the age of people who have Overdose when taking Kerlone? *

What are other drugs people take besides Kerlone? *

Trazodone Hydrochloride: 5 people, 38.46%
Topiramate: 5 people, 38.46%
Topamax: 5 people, 38.46%
Celexa: 5 people, 38.46%
Acarbose: 2 people, 15.38%
Actonel: 2 people, 15.38%
Ramipril: 2 people, 15.38%
Pantoprazole: 2 people, 15.38%
Levothyroxine Sodium: 2 people, 15.38%
Lasix: 2 people, 15.38%

What are other side effects people have besides Overdose? *

Joint Pain: 6 people, 46.15%
Heart Rate Increased: 6 people, 46.15%
Nervousness: 5 people, 38.46%
Adverse Drug Reaction: 5 people, 38.46%
Weakness: 5 people, 38.46%
Feeling Abnormal: 5 people, 38.46%
Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 5 people, 38.46%
Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body): 5 people, 38.46%
Fear: 5 people, 38.46%
Psychomotor Hyperactivity (feelings of extreme restlessness): 5 people, 38.46%

What are the existing conditions these people have? *

Migraine (headache): 5 people, 38.46%
Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures): 5 people, 38.46%
Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body): 5 people, 38.46%
Thrombophlebitis (swelling (inflammation) of a vein caused by a blood clot): 1 person, 7.69%
Osteoporosis (bones weak and more likely to break): 1 person, 7.69%
High Blood Pressure: 1 person, 7.69%
Acromegaly (body produces too much growth hormone, leading to excess growth of body tissues): 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Kerlone and have Overdose?

- Check whether Overdose is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Kerlone:

Kerlone (941 reports)

Overdose treatments and more:

Overdose (229,245 reports)

Browse all side effects of Kerlone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Overdose:

Overdose (2,217 drugs)

Browse all the conditions that are associated with Overdose:

Overdose (2,472 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on betaxolol hydrochloride (the active ingredients of Kerlone) and Kerlone (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.